Hims vs Medvi

Choose hims if: You need men's health platform addressing weight loss plus other conditions (erectile dysfunction, hair loss, mental health, skincare), want men's health medical team with expertise in testosterone, sexual function, male metabolic factors vs gender-neutral obesity treatment, seek healthcare consolidation under single provider relationship managing multiple men's health dimensions, value the longest-established telehealth platform (7+ years, millions served) for maximum treatment continuity confidence, need both semaglutide AND tirzepatide medication flexibility, or recognize men managing multiple conditions (weight + ED, weight + hair loss) benefit from integrated multi-category platform vs separate budget specialist subscriptions.

Choose Medvi if: You exclusively need ultra-budget weight loss without other men's health services, prioritize absolute lowest GLP-1 pricing ($2,388-2,988/year) accepting medication-only limitation, satisfied with semaglutide-only formulary without tirzepatide access, accept ~3 years of history vs hims 7+ years extensive track record, don't require erectile dysfunction treatment, hair loss medications, mental health support, or other men's health services, seek bare-bones medication access without lifestyle programming support, or extreme cost sensitivity drives decision-making over certainty, men's health specialization, or multi-category utility.

Bottom line: hims and Medvi represent dramatically different healthcare models - multi-category men's health platform vs ultra-budget medication-only weight loss specialist. hims operates as established men's health consolidation ($49-139/month consultations plus medication costs, total $2,000-4,500+/year estimated) with 7+ years of history providing weight management integrated with erectile dysfunction, hair loss, mental health, skincare, and primary care through men's health medical team. Medvi functions as ultra-budget weight loss specialist ($199-249/month bundled, $2,388-2,988/year) with ~3 years track record providing semaglutide-only medication with minimal physician consultations through highly streamlined operations serving exclusively obesity treatment. Medvi delivers lowest-cost GLP-1 access but dramatic service limitations: medication-only model, semaglutide-only formulary, gender-neutral treatment, zero multi-category utility. hims higher costs but services: men's health expertise, multi-category consolidation (weight + ED + hair loss under single platform), the 7+ years vs ~3 years gap, treatment flexibility (semaglutide AND tirzepatide options). For men exclusively needing budget semaglutide accepting medication-only limitation and single-purpose platform, Medvi delivers lowest cost. For men managing multiple men's health conditions or valuing men-specific expertise and healthcare consolidation, hims approach justifies higher costs through multi-utility, care, and extensive track record. Platform choice depends on budget constraints, single vs multi-condition needs, value of men's health specialization, importance of track record, and whether healthcare consolidation across multiple men's health dimensions justifies hims premium over Medvi ultra-budget medication-only model.